Innoviva, Inc.
CIK 0001080014
Director10% Owner
Filings
4
Latest Jan 12, 2023
Issuers covered
2
Showing
4 of 4
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 0% | -14.9% | -14.9% | -7.8% | -22.0% |
| 90 days | 2 | 0% | -23.2% | -23.2% | -21.3% | -25.2% |
| 180 days | 2 | 0% | -14.8% | -14.8% | -12.7% | -16.9% |
| 365 days | 2 | 0% | -55.0% | -55.0% | -44.1% | -65.8% |
Issuers
Companies where Innoviva, Inc. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | 3 | Jan 12, 2023 |
| ETTX | Entasis Therapeutics Holdings Inc. | 1 | Feb 23, 2022 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|